Evidence map›Paper›PMID 41103024›Full record

ArticleCancer communications (London, England)2025

Intranuclear paraspeckle-circular RNA TACC3 assembly forms RNA-DNA hybrids to facilitate MASH-related hepatocellular carcinoma growth in an m

Jingbo Fu, Yanping Wei, Yun Yang, Xinwei Yang, Tao Ouyang, Xianming Wang, Shuzhen Chen, Zenglin Liu, Yu Su, Jing Fu and 13 more

Abstract read
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. CircPRKCA Promotes NSCLC Progression via miR-200b-3p/FRMD6/SNAI2 Axis.International journal of molecular sciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jingbo FuNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Yanping WeiNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Yun YangDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Xinwei YangDepartment of Biliary Tract Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Tao OuyangNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Xianming WangDepartment of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, P. R. China.
Shuzhen ChenNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Zenglin LiuDepartment of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, P. R. China.
Yu SuNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Jing FuNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Miao YuNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Haihua QianNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Hao SongNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Shuo XuNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Ru ZhaoNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Xue JiangNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Yunfei HuoNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Man ZhangNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Pinhua YangDepartment of Biliary Tract Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Zhao YangDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Kui WangDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Liang LiNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.
Hongyang WangNational Center for Liver Cancer, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P. R. China.ORCID 0000-0002-4709-3334

Funding

National Natural Science Foundation of China 81830054National Natural Science Foundation of China 81902940National Natural Science Foundation of China 81902942National Natural Science Foundation of China 81988101National Natural Science Foundation of China 82172896National Natural Science Foundation of China 82173146National Natural Science Foundation of China 82303070National Natural Science Foundation of China 82472765National Natural Science Foundation of China 91859205Natural Science Foundation of Shanghai 19ZR1400300Shanghai Key Laboratory of Hepatobiliary Tumor BiologyShanghai Top Young Talents Program, Foundation of Shanghai Shenkang Hospital Development Center SHDC2020CR2011AThe Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai, ChinaYouth Elite Scientist Sponsorship Program by Cast 2023QNRC001
6 · The paper itself

Abstract

backgroundMetabolic dysfunction-associated steatohepatitis (MASH) is anticipated to become the leading cause of hepatocellular carcinoma (HCC). Accumulating evidence indicates that N6-methyladenosine (m

methodsEpitranscriptomic microarray and in situ hybridization assays were used to validate circTACC3 expression in MASH-related HCC specimens. Palmitic acid (PA) and oleic acid (OA) was applied to NAC-organ assembled three-dimensional-organoid and HCC cell lines to imitate pathological lipid overload. The circTACC3-paraspeckle interaction was studied utilizing fluorescence lifetime imaging microscopy-Forster resonance energy transfer. An integrative analysis combining DNA-RNA immunoprecipitation combined with chromatin isolation by RNA purification (DRIP-ChIRP), γH2AX cleavage under target and tagmentation, and high-throughput/resolution chromosome conformation capture sequencing were used to study chromatin remodeling induced by circTACC3-formed RNA-DNA hybrids (R loops) at DNA double-strand break (DSB) loci during lipid overload.

resultsThe most prevalent m

conclusionsThe m

Indexed as

AdenosineCarcinoma, HepatocellularLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseRNA, CircularAdolescentAdultCell Line, TumorDNAFemaleGene Expression Regulation, NeoplasticHepatocytesHumansLipid MetabolismLiverMaleAdenosineDNAN-methyladenosineRNA, Circularchromatin remodelingcircular RNADNA double‐strand breakhepatocellular carcinomalipid overloadmetabolic dysfunction‐associated steatohepatitisN6‐methyladenosine modificationparaspeckleR loop

Identifiers

PMID41103024
PMCPMC12629860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.